Trader sentiment in the Polymarket acquisition market hinges on recent takeover rumors amid a booming tech and biotech M&A landscape driven by AI consolidation and GLP-1 drug competition. Viking Therapeutics leads biotech targets at 31% implied probability after CNBC flagged it as a prime big pharma buyout candidate for its VK2735 obesity therapy, with Phase 3 trials slated for late 2026. Perplexity AI draws 29% odds on speculation of AI lab acquisitions, bolstered by its $20 billion valuation and Microsoft cloud deal, though no confirmed bids have emerged. PayPal's 27% reflects February takeover buzz post-weak guidance, positioning it for fintech synergies. Watch Q2 earnings and regulatory filings for shifts, as prediction markets aggregate real-money bets on these dynamics.
Resumo experimental gerado por IA com dados do Polymarket · AtualizadoQuais empresas serão adquiridas antes de 2027?
Quais empresas serão adquiridas antes de 2027?
$17,306,346 Vol.

Caesars Entertainment
61%

Pizza Hut
37%

Ubisoft
30%

Perplexity AI
29%

GitLab
24%

Viking Therapeutics
22%

PayPal
21%

Snapchat
17%

BP
21%

Lovable
16%

Nebius Group
14%

Anthropic
11%

Zoom Video Communications
10%

OpenAI
10%
$17,306,346 Vol.

Caesars Entertainment
61%

Pizza Hut
37%

Ubisoft
30%

Perplexity AI
29%

GitLab
24%

Viking Therapeutics
22%

PayPal
21%

Snapchat
17%

BP
21%

Lovable
16%

Nebius Group
14%

Anthropic
11%

Zoom Video Communications
10%

OpenAI
10%
Mergers where the listed company is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between the listed company and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from the listed company and/or its leadership; however, a consensus of credible reporting will also be used.
Mercado Aberto: Nov 24, 2025, 12:48 PM ET
Resolver
0x65070BE91...Mergers where the listed company is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between the listed company and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from the listed company and/or its leadership; however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Trader sentiment in the Polymarket acquisition market hinges on recent takeover rumors amid a booming tech and biotech M&A landscape driven by AI consolidation and GLP-1 drug competition. Viking Therapeutics leads biotech targets at 31% implied probability after CNBC flagged it as a prime big pharma buyout candidate for its VK2735 obesity therapy, with Phase 3 trials slated for late 2026. Perplexity AI draws 29% odds on speculation of AI lab acquisitions, bolstered by its $20 billion valuation and Microsoft cloud deal, though no confirmed bids have emerged. PayPal's 27% reflects February takeover buzz post-weak guidance, positioning it for fintech synergies. Watch Q2 earnings and regulatory filings for shifts, as prediction markets aggregate real-money bets on these dynamics.
Resumo experimental gerado por IA com dados do Polymarket · Atualizado
Cuidado com os links externos.
Cuidado com os links externos.
Frequently Asked Questions